iShares U.S. Healthcare ETF $IYH Shares Newly Acquired by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. purchased a new stake in iShares U.S. Healthcare ETF (NYSEARCA:IYH) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 10,040 shares of the company’s stock, valued at approximately $718,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in IYH. Park Avenue Securities LLC acquired a new position in iShares U.S. Healthcare ETF during the 3rd quarter worth approximately $12,984,000. Ninety One SA Pty Ltd acquired a new stake in iShares U.S. Healthcare ETF in the third quarter valued at approximately $11,002,000. Capital Investment Advisors LLC bought a new stake in shares of iShares U.S. Healthcare ETF during the third quarter worth $4,803,000. Royal Bank of Canada grew its stake in shares of iShares U.S. Healthcare ETF by 7.8% during the first quarter. Royal Bank of Canada now owns 899,816 shares of the company’s stock worth $55,466,000 after buying an additional 64,913 shares during the last quarter. Finally, Gerald Baker Financial Group LLC bought a new stake in shares of iShares U.S. Healthcare ETF during the first quarter worth $3,539,000.

iShares U.S. Healthcare ETF Stock Performance

Shares of NYSEARCA:IYH opened at $79.85 on Thursday. iShares U.S. Healthcare ETF has a 52-week low of $59.63 and a 52-week high of $80.05. The company has a market capitalization of $4.76 billion, a PE ratio of 33.46 and a beta of 0.55. The company has a fifty day moving average of $72.98 and a 200-day moving average of $66.99.

About iShares U.S. Healthcare ETF

iShares U.S. Healthcare ETF (the Fund), formerly iShares Dow Jones U.S. Healthcare Sector Index Fund (the Fund) is a non-diversified exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Health Care Index (the Index). The Index measures the performance of the healthcare sector of the United States equity market, and includes companies in the industry groups, such as healthcare equipment and services, pharmaceuticals and biotechnology.